0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.06%
Revenue growth under 50% of ANO.AX's 62.13%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
28.92%
Gross profit growth under 50% of ANO.AX's 251.94%. Michael Burry would be concerned about a severe competitive disadvantage.
380.62%
EBIT growth above 1.5x ANO.AX's 155.25%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
380.62%
Operating income growth at 50-75% of ANO.AX's 648.74%. Martin Whitman would doubt the firm’s ability to compete efficiently.
1164.40%
Net income growth above 1.5x ANO.AX's 161.71%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.99%
Share reduction while ANO.AX is at 0.62%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
81.42%
Positive OCF growth while ANO.AX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-360.42%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-74.99%
Negative 10Y revenue/share CAGR while ANO.AX stands at 223.10%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-42.26%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-3.11%
Negative 3Y CAGR while ANO.AX stands at 6.96%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
145.92%
10Y OCF/share CAGR above 1.5x ANO.AX's 77.99%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
26672.25%
Positive OCF/share growth while ANO.AX is negative. John Neff might see a comparative advantage in operational cash viability.
184.38%
3Y OCF/share CAGR under 50% of ANO.AX's 878.66%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
110.42%
Below 50% of ANO.AX's 4293.06%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
14569.42%
Positive 5Y CAGR while ANO.AX is negative. John Neff might view this as a strong mid-term relative advantage.
10.26%
Positive short-term CAGR while ANO.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
479.91%
3Y equity/share CAGR above 1.5x ANO.AX's 0.05%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-56.88%
Firm’s AR is declining while ANO.AX shows 53.52%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
12.80%
We show growth while ANO.AX is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
35.81%
Asset growth above 1.5x ANO.AX's 3.20%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.76%
BV/share growth above 1.5x ANO.AX's 2.14%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
15122.66%
We have some new debt while ANO.AX reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
92.32%
We increase R&D while ANO.AX cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-33.57%
We cut SG&A while ANO.AX invests at 14.86%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.